Three candidate blood biomarkers, COPZ1, EFTUD2 and PTBP1, correlated with clinical features in early stage drug-naïve PD patients suggesting they may be useful for patient stratification according to disease severity measures. The gene discussed is PTBP1; the disease is Parkinson disease.